Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AuroraBlue Flavon-Plus Formula is a specialized nutraceutical complex centered on **AuroraBlue**, a proprietary blend of wild-harvested Alaskan berries including bog blueberry (*Vaccinium uliginosum*), oval-leaf blueberry (*Vaccinium ovalifolium*), thin-leaf blueberry (*Vaccinium membranaceum*), and dwarf bilberry (*Vaccinium cespitosum*). Developed by Denali BioTechnologies, this formula leverages the unique phytochemical profile of berries grown in the extreme Arctic environment, which results in significantly higher concentrations of anthocyanins, flavonols, and other polyphenols compared to standard cultivated varieties. The formula is designed to provide potent antioxidant support and neuroprotection by neutralizing reactive oxygen species and modulating inflammatory signaling pathways. It is primarily indicated for the promotion of cognitive health, cardiovascular support, and the mitigation of oxidative stress associated with aging.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AuroraBlue Flavon-Plus Formula.